FDA Inspection 999614 — Michael L. Swank, M.D.
The FDA completed an inspection of Michael L. Swank, M.D. on Jan 19, 2017 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 19, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Cincinnati, OH (United States)
Additional Details
Clinical Investigator (CI)